首页> 美国卫生研究院文献>Marine Drugs >Preparation and Identification of ACE Inhibitory Peptides from the Marine Macroalga Ulva intestinalis
【2h】

Preparation and Identification of ACE Inhibitory Peptides from the Marine Macroalga Ulva intestinalis

机译:海洋Macroalga Ulva肠道的ACE抑制肽的制备和鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from seaweed represent a potential source of new antihypertensive. The aim of this study was to isolate and purify ACE inhibitory peptides (ACEIPs) from the protein hydrolysate of the marine macroalga Ulva intestinalis. U. intestinalis protein was hydrolyzed by five different proteases (trypsin, pepsin, papain, α-chymotrypsin, alcalase) to prepare peptides; compared with other hydrolysates, the trypsin hydrolysates exhibited the highest ACE inhibitory activity. The hydrolysis conditions were further optimized by response surface methodology (RSM), and the optimum conditions were as follows: pH 8.4, temperature 28.5 °C, enzyme/protein ratio (E/S) 4.0%, substrate concentration 15 mg/mL, and enzymolysis time 5.0 h. After fractionation and purification by ultrafiltration, gel exclusion chromatography and reverse-phase high-performance liquid chromatography, two novel purified ACE inhibitors with IC50 values of 219.35 μM (0.183 mg/mL) and 236.85 μM (0.179 mg/mL) were obtained. The molecular mass and amino acid sequence of the ACE inhibitory peptides were identified as Phe-Gly-Met-Pro-Leu-Asp-Arg (FGMPLDR; MW 834.41 Da) and Met-Glu-Leu-Val-Leu-Arg (MELVLR; MW 759.43 Da) by ultra-performance liquid chromatography-tandem mass spectrometry. A molecular docking study revealed that the ACE inhibitory activities of the peptides were mainly attributable to the hydrogen bond and Zn(II) interactions between the peptides and ACE. The results of this study provide a theoretical basis for the high-valued application of U. intestinalis and the development of food-derived ACE inhibitory peptides.
机译:来自海藻的血管紧张素I转换酶(ACE)抑制肽代表了新的抗高血压药的潜在来源。这项研究的目的是从海洋大型藻类Ulva肠的蛋白质水解物中分离和纯化ACE抑制肽(ACEIP)。用五种不同的蛋白酶(胰蛋白酶,胃蛋白酶,木瓜蛋白酶,α-胰凝乳蛋白酶,碱性蛋白酶)水解肠道肠蛋白,制备多肽;与其他水解产物相比,胰蛋白酶水解产物表现出最高的ACE抑制活性。水解条件通过响应面法(RSM)进一步优化,最佳条件如下:pH 8.4,温度28.5°C,酶/蛋白质比(E / S)4.0%,底物浓度15 mg / mL和酶解时间5.0 h。经过超滤,凝胶排阻色谱和反相高效液相色谱分离和纯化后,获得了两种新型的纯化的ACE抑制剂,IC50值为219.35μM(0.183 mg / mL)和236.85μM(0.179 mg / mL)。 ACE抑制肽的分子量和氨基酸序列被鉴定为Phe-Gly-Met-Pro-Leu-Asp-Arg(FGMPLDR; MW 834.41 Da)和Met-Glu-Leu-Val-Leu-Arg(MELVLR; GMVDR; Mg-Leu-Val-Leu-Arg)。 MW 759.43 Da)的超高效液相色谱-串联质谱分析。分子对接研究表明,肽的ACE抑制活性主要归因于肽与ACE之间的氢键和Zn(II)相互作用。这项研究的结果为肠道菌的高价值应用和食品衍生的ACE抑制肽的开发提供了理论基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号